AMCP Regulatory NewsBreaks
Resource

Regulatory NewsBREAK: CMS Issues Notice of Benefit and Payment Parameters

On May 18, 2026, the Centers for Medicare and Medicaid Services (CMS) published the final Notice of Benefit and Payment Parameters for 2027 (NBPP). The NBPP updates Affordable Care Act (ACA) marketplace standards and payment parameters for plan year 2027, qualified health plan (QHP) standards, risk adjustment, enrollment policies, Basic Health Program (BHP) policies, and implementation of provisions from the One Big Beautiful Bill legislation (Pub. L. 119-21).
Payment Systems
Lilly Logo
Resource

AMCP Research Institute Launches National Cardiometabolic Research Initiative to Advance Comprehensive Cardiometabolic Care Models

The AMCP Research Institute (ARI) announced the launch of Cardiometabolic Health Real-world Outcomes & Management Evaluation (CHROME), a multisite research initiative designed to evaluate the effectiveness, structure, and economic impact of comprehensive cardiometabolic care models such as Cardiometabolic Centers of Excellence (CoEs) and dedicated obesity clinics. This collaborative research initiative is supported by Lilly and will generate real-world evidence intended to help inform best-practice recommendations and implementation guidance to support scalable cardiometabolic care nationwide.
Chelsey Headshot
Press Releases

AMCP Announces 2026–2027 Executive Fellow in Health Care Association Leadership

The Academy of Managed Care Pharmacy (AMCP) has selected Chelsey Sparks, PharmD candidate at Lipscomb University in Nashville, TN, as its 2026–2027 Executive Fellow in Health Care Association Leadership. This year-long program offers a comprehensive, in-depth learning experience for pharmacists interested in health care association leadership or managed care pharmacy.
AMCP Regulatory NewsBreaks
Regulatory NewsBREAK

Regulatory NewsBREAK: CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices

On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate Medicare coverage for certain FDA-designated Breakthrough Devices by aligning evidence requirements and coverage decisions earlier in development.
Legislation & Regulation